PHARMACOGENETIC DIRECTED DOSING LEADS TO OPTIMIZED VORICONAZOLE LEVELS IN PEDIATRIC PATIENTS RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANTS

被引：0
|
作者：
Teusink, Ashley
Vinks, Alexander
Zhang, Kejian
Davies, Stella
Filipovich, Alexandra
Fukuda, Tsuyoshi
Mehta, Parinda
机构：
[1] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA
[2] Cincinnati Childrens Hosp, CIBMTR, Cincinnati, OH USA
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [21] CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis
    Patel, Jai N.
    Robinson, Myra M.
    Hamadeh, Issam
    Shahid, Zainab
    Symanowski, James T.
    Plesca, Dragos
    Croom, Margaret
    Trivedi, Jigar
    Steuerwald, Nury M.
    Avalos, Belinda R.
    Copelan, Edward A.
    BLOOD, 2016, 128 (22)
  • [22] Voriconazole Therapeutic Drug Monitoring in a Pediatric Hematopoietic Stem Cell Transplant Center
    Kim, Abby
    Elder, Joshua
    Cheerva, Alexandra
    Lucas, Kenneth
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S368 - S368
  • [23] Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants
    Simon, Arne
    Besuden, Mette
    Vezmar, Sandra
    Hasan, Carola
    Lampe, Dagmar
    Kreutzberg, Sigrid
    Glasmacher, Axel
    Bode, Udo
    Fleischhack, Gudrun
    SUPPORTIVE CARE IN CANCER, 2007, 15 (02) : 213 - 220
  • [24] Zygomycosis in allogeneic hematopoietic stem cell transplant recipients receiving prophylactic voriconazole.
    De Magalhaes-Silverman, M
    Carter, T
    Gingrich, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 593S - 593S
  • [25] Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants
    Arne Simon
    Mette Besuden
    Sandra Vezmar
    Carola Hasan
    Dagmar Lampe
    Sigrid Kreutzberg
    Axel Glasmacher
    Udo Bode
    Gudrun Fleischhack
    Supportive Care in Cancer, 2007, 15 : 213 - 220
  • [26] LIPID ABNORMALITIES AND METABOLIC SYNDROME IN PEDIATRIC PATIENTS WHO RECEIVED HEMATOPOIETIC STEM CELL TRANSPLANTS
    Richardson, T. H.
    Ashraf, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 406 - 406
  • [27] The Late Effects of Hematopoietic Stem Cell Transplants in Pediatric Patients: A 25-Year Review
    Lee, Samantha Lai-Ka
    Nguyen, Quynh-Nhu
    Ho, Cindy
    James, Simon
    Kaur, Amreeta
    Lim, Angelina
    Tiedemann, Karin
    Zacharin, Margaret
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [28] OUTCOMES OF SECOND MYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTS IN PEDIATRIC PATIENTS WITH RECURRENT HEMATOLOGIC MALIGNANCIES
    Lehmann, L. E.
    Buonanno, M.
    Duncan, C. N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 74 - 74
  • [29] PROVIDING CARE TO NAVAJO CHILDREN AND FAMILIES RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANTS
    Abramovitz, Linda
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 723 - 723
  • [30] Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants
    Nara, Miho
    Takahashi, Naoto
    Miura, Masatomo
    Niioka, Takenori
    Kagaya, Hideaki
    Fujishima, Naohito
    Saitoh, Hirobumi
    Kameoka, Yoshihiro
    Tagawa, Hiroyuki
    Hirokawa, Makoto
    Sawada, Kenichi
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (06) : 1321 - 1329
12345